Bringing Life Changing Innovations to Patients
About Magle Group
The Magle Group aims to establish itself as a leader in high-quality life-changing healthcare innovations to meet medical needs through scientific excellence.
Magle Group consistently delivers cutting-edge products through streamlined development, cost reduction, and expedited time-to-market strategies. This approach ensures stable sales and profits, driving sustained growth and innovation across our entire organization.
Patient-centric innovation
At Magle Group, we prioritize patient-centric innovation by delivering cutting-edge products that harness our diverse technologies. Through streamlined development, cost-efficient processes, and accelerated time-to-market strategies, we ensure reliable solutions that enhance patient outcomes. This commitment fosters continuous innovation and drives sustainable growth across our organization. Our commitment is to place patients first by delivering innovative medical solutions that transform lives and advance global healthcare.
Our Story
At Magle Group, patients are at the heart of everything we do. Guided by our aspiration to bring life-changing healthcare innovations to those in need, we strive to develop transformative solutions that improve quality of life and address critical unmet medical needs.
Our work spans three key medical technologies that directly enhance patient care:
- Degradable Starch Microspheres (DSM): Targeted solutions addressing specific medical challenges.
- Amniotic-Based Stem Cells: Regenerative innovations designed to accelerate healing and recovery.
- Dextran Derivatives: Advanced technologies enhancing safety and efficacy in healthcare treatments.
Operating from facilities in Sweden and Denmark, with a European sales network based in Germany. Our team members of 150 experts ensures our solutions reach patients efficiently. Through our Contract Development and Manufacturing Organization (CDMO) services, we streamline the development and delivery of pioneering therapies, ensuring patients access breakthrough treatments faster.
Our Technologies
DSM
At Magle Group, our Degradable Starch Microspheres (DSM) are advanced, biodegradable particles designed for various medical applications. DSM technology can be delivered to the body in a variety of formulations, enhancing treatment efficacy and improving patient outcomes. Versatile and reliable, our DSM technology supports applications in oncology, pain management, regenerative medicine, and more, offering efficient solutions for advanced healthcare treatments.
Dextran
At Magle Group, our dextran technology is a versatile biopolymer used in a wide range of medical and biopharma applications. Dextran can be formulated in various ways to support drug delivery, wound care, tissue engineering, and biopharmaceutical processes. It enhances treatment efficacy, improves patient outcomes, and supports regenerative medicine. Reliable and adaptable, our dextran technology offers efficient solutions for advanced healthcare treatments.
Stem cells
At Magle Group, our amniotic-based stem cell technology is dedicated to advancing regenerative medicine. These stem cells, sourced from amniotic fluid, have unique properties that promote healing and tissue regeneration. They can be used in various formulations for treating conditions such as inflammatory diseases, wound healing, and organ repair. Our cutting-edge stem cell technology enhances treatment efficacy and patient outcomes, offering innovative solutions for advanced medical care.
Driving Healthcare Innovation
Magle Group combines expertise in pharmaceuticals, advanced therapeutics, biopolymers, and DSM solutions to bring impactful products to market. Our growth trajectory reflects a commitment to delivering better patient outcomes, fostering partnerships, and advancing medical science.
Building Growth: Magle Group’s Journey
Since 2015, Magle Group has demonstrated a commitment to strategic growth and innovation.
Explore our Business Units
Magle Chemoswed
We serve companies in the pharmaceutical and medical device industry, providing comprehensive services from development through manufacturing on a contract basis. Together with our partners, we take innovations from idea to product.
Magle Biopolymers
We are a world leading manufacturer of dextran and dextran derivatives that helps you bring your bio-polymer-based solutions from idea to market with tailored solutions for your project.
Magle PharmaCept
It is our absolute commitment to ensure we supply high-quality products to patients, and healthcare professionals. Our emphasis is on conducting research and providing healthcare professionals with scientific evidence.
Magle Biopharma
We specialize in the development and production of stem cell-based therapies for both investigational and GMP use. we leverage our deep industry knowledge, innovative technologies, and robust processes to deliver unparalleled results.
